市場調查報告書
商品編碼
1433457
全球下肢義肢市場 2023-2030年Global Lower Limb Prosthetics Market 2023-2030 |
預計在預測期(2023-2030年),全球下肢義肢市場將以5.2%的CAGR成長。推動下肢義肢市場的重要因素包括健全的醫療基礎設施、增加下肢義肢研發投資以及不斷增加的創傷和事故病例。道路事故會導致各種骨頭骨折,包括四肢的骨折,例如腿、膝蓋和腳。根據英國政府提供的國家統計資料,2022年,共有29,742人死亡或重傷(KSI),登記死亡病例1,711例,各類嚴重傷亡人數135,480人。因此,英國的外科手術數量日益增加。
全球下肢義肢市場依技術、類型和最終用途進行細分。根據技術,市場分為電動下肢義肢、傳統下肢義肢和混合式下肢義肢。根據類型,市場分為義肢腿、義肢足、義肢膝、義肢髖和義肢踝。此外,根據最終用途,市場細分為醫院、診所等。其他包括研究所。在最終用途中,由於可負擔性、可近性和功能的改善,預計醫院細分市場將佔據相當大的市場佔有率。
在這些類型中,義肢髖關節細分市場預計將在預測期內成長。此細分市場的推動因素是人口中關節炎的盛行率不斷上升以及假體髖關節手術的技術進步。根據美國疾病管制與預防中心的資料,2019年至2021年期間,約五分之一的美國成年人(21.2%)或約 5,320 萬人患有醫生診斷的關節炎。與男性(16.3%)相比,女性(20.9%)更容易患關節炎。因此,關節炎發病率的增加預計將推動對義肢髖關節的需求。
全球下肢義肢市場根據地理位置進一步細分,包括北美(美國和加拿大)、歐洲(英國、義大利、西班牙、德國、法國和歐洲其他地區)、亞太地區(印度、中國、日本、韓國、亞洲其他地區)以及世界其他地區(中東和非洲、拉丁美洲)。其中,北美在全球市場中佔有相當大的佔有率。下肢義肢的需求不斷成長,老年人口和不斷增加的醫療保健支出對區域市場做出了貢獻。
在所有地區中,亞太地區預計在預測期內將以顯著的CAGR成長。在人口成長、人口老化和嚴重傷害數量不斷增加等因素的推動下,亞太地區糖尿病等慢性病的盛行率上升。中國在亞太下肢義肢市場佔據主導地位,其次是印度、日本、韓國和其他亞太經濟體。由於下肢義肢的使用不斷增加以及糖尿病等慢性疾病的盛行率不斷上升,中國的下肢義肢市場經歷成長。根據世界衛生組織的資料,中國是全球糖尿病患者數量最多的國家,2019年有近1.16億活躍病例,預計到2040年將增加到1.5億。預計2009年中國糖尿病盛行率為3.9%,預計到2030年將增至5.4%。2020-2030年中國20-79 歲成年人糖尿病盛行率預計將從8.2%增至9.7%。
服務下肢義肢市場的主要公司包括 Blatchford Inc.、Bauerfeind AG、Otto Bock HealthCare LP、WillowWood Global LLC. 等。市場參與者透過各種策略(包括併購、夥伴關係、合作、融資和新產品發布),為市場成長做出了巨大貢獻,以保持市場競爭力。例如,2021年 3月,Boston Orthotics & Prosthetics 與俄亥俄州中部矯形與義肢中心(COOP)合作,為俄亥俄州中部的患者和家庭(包括全國兒童醫院的患者和家庭)提供兒科矯形器和義肢服務。
Global Limb Lower Prosthetics Market Size, Share & Trends Analysis Report by Technology (Electric Powered Lower Extremity Prosthetics, Conventional Lower Extremity Prosthetics, and Hybrid Lower Extremity Prosthetics), by Type (Prosthetics Leg, Prosthetics Foot, Prosthetics Knee, Prosthetics Hip, and Prosthetics Ankle), by End-Use (Hospitals, Clinics, and Others), Forecast Period (2023-2030)
The global lower limb prosthetics market is anticipated to grow at a CAGR of 5.2% during the forecast period (2023-2030). Significant factors contributing to the limb lower prosthetics market include robust healthcare infrastructure, increasing investment in R&D of the limb lower prosthetics, and increasing number of trauma and accident cases. Road accidents lead to fractures of various bones, including those in the extremities such as the legs, knee, and foot. According to the national statistics provided by the UK government, in 2022, 29,742 people were killed or seriously injured (KSI) casualties, 1,711 fatalities cases were registered and 135,480 were casualties of all severities. As a result, the number of surgical procedures is increasing in the UK.
The global lower limb prosthetics market is segmented on the by technology, type, and end-use. Based on the technology, the market is sub-segmented into electric powered lower extremity prosthetics, conventional lower extremity prosthetics, and hybrid lower extremity prosthetics. Based on the type, the market is sub-segmented into prosthetics leg, prosthetics foot, prosthetics knee, prosthetics hip, and prosthetics ankle. Further, based on the end-use, the market is sub-segmented into hospitals, clinics, and others. Others includes Research Institute. Among the end-use, the hospitals sub-segment is anticipated to hold a considerable share of the market, owing to the affordability, accessibility, and improved function.
Among the types, prosthetics hip sub-segments expected to grow over the forecast period. The segment is driven by the increasing prevalence of arthritis among the population and technological advancements in prosthetic hip surgeries. According to the Centers for Disease Control and Prevention, during 2019-2021, about 1 in 5 US adults (21.2%) or about 53.2 million people had doctor-diagnosed arthritis. Arthritis was more common among women (20.9%) compared to men (16.3%). Thus, the increasing incidence of arthritis is expected to drive the demand for prosthetics hip.
The global lower limb prosthetics market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, North America held considerable share in the global market. The growing demand for lower limb prosthetics, increasing geriatric population, and rising healthcare expenditure contributing to the regional market.
Among all regions, the Asia-Pacific region is anticipated to grow at a significant CAGR over the forecast period. The Asia-Pacific region is experiencing a rise in the prevalence of chronic diseases such as diabetes, driven by factors such as population growth, aging demographics, and the growing numbers of severe injuries. China dominates the Asia-Pacific lower limb prosthetics market followed by India, Japan, South Korea, and the rest of the Asia-Pacific economies. The lower limb prosthetics market in China is experiencing growth owing to the increasing adoption of lower limb prosthetics and increasing prevalence of chronic disorders, such as diabetes. According to the World Health Organization, China has the highest number of diabetic patients globally, with nearly 116 million active cases in 2019, and is expected to increase to 150 million by 2040. The estimated diabetes prevalence rate in China in 2009 was 3.9% and is projected to increase to 5.4% by 2030. The prevalence of diabetes in Chinese adults aged 20-79 years is projected to increase from 8.2% to 9.7% during 2020-2030.
The major companies serving the lower limb prosthetics market include Blatchford Inc., Bauerfeind AG, Otto Bock HealthCare LP, WillowWood Global LLC., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in March 2021, Boston Orthotics & Prosthetics partnered with the Central Ohio Orthotic & Prosthetic Center (COOP) to provide pediatric orthotic and prosthetic services for patients and families in Central Ohio, including those of Nationwide Children's Hospital.